交易中 10-07 10:46:26 美东时间
-0.045
-0.26%
Gilead Sciences (NASDAQ:GILD) was upgraded to overweight by Wells Fargo, which cited the upcoming launch of its PrEP treatment for the prevention of HIV. The investment bank said it believes the PrEP ...
22分钟前
北京时间2024年10月05日01时11分,Deckers Outdoor Corporation(DECK.us)股票出现异动,股价大幅拉升5.00%。截至发...
10-05 01:11
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries (NYSE:TEVA), and mAbxience, Thursday reported a new global licensing agreement for the development of an anti PD...
10-03 22:51
The Centers for Medicare & Medicaid Services (CMS) has added several changes to the Medicare price negotiation process expected to occur next year, leading to revised prices for up to 15 pharmaceutica...
10-03 20:02
Financing to advance lead asset RTX001, an engineered, pro-regenerative macroph...
10-03 14:30
Gilead (NASDAQ:GILD) said it has signed licensing agreements with six generic drugmakers to produce and supply generic formulations of its HIV prevention drug lenacapavir in 120 mostly lower income na...
10-02 21:47
<span> <meta content="no-referrer" name="referrer"></span><blockquote> <p><strong>一、大盘概览</strong></p></blockquote><p>华盛资讯10月02日讯,截至收盘,道琼斯工业平均指数跌幅0.41%,报42156.97点;纳斯达克综合指数跌幅1.53%,报17910.36点;标准普尔500指数跌幅0.93%,报5708.75点。</p><p>美股盘前,三大股指期货小幅走低,截至发稿,纳指期货 $NQmain 跌幅0.27%,标普500指数期货 $ESmain 跌幅0.18%,道指期货 $YMmain 跌幅0.21%。</p><blockquote> <p><strong>二、期权成交量TOP 10</strong></p></blockquote><p>英伟达 $NVDA :隔夜跌3.66%,当日期权成交总量达371万张,较前一日增加134.77万张,环比前一日放量0
10-02 17:18
Shares of Teva Pharmaceutical Industries (NYSE: TEVA) are down Tuesday. Here's what you need to know.
10-02 01:42
Israeli drugmaker Teva Pharmaceuticals (NYSE:TEVA) announced Tuesday the market launch of the first and only U.S. generic for Sandostatin LAR, an antidiarrheal medication marketed by Swiss pharmaceuti...
10-01 21:29
Truist Securities raises the price target for Corcept Therapeutics to $76, driven by robust Korlym sales and promising relacorilant trials. The analyst highlights significant growth potential in the Cushing's syndrome market.
10-01 03:01